OBM Geriatrics is an Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.

Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.

Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.

Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.

Publication Speed (median values for papers published in 2023): Submission to First Decision: 5.7 weeks; Submission to Acceptance: 17.9 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)

Geriatric Rehabilitation

A section of OBM Geriatrics

Section Introduction

The section of the journal OBM Geriatrics is devoted to publishing relevant research in the areas of normal aging due to disuse and deconditioning, cardiovascular problems like vascular disease and stroke, and skeletal problems including osteoporosis and osteoarthritis conditions such as knee and hip replacements. Geriatric rehabilitation aims to restore function or enhance residual functional capability and improving the quality of life in older people, particularly those with disabling impairments and/or Frailty. Current rehabilitation practice focuses on function and well-being, not exclusively on disease. With increased age, patients often face many physical and emotional changes that can affect level of physical, mental, social function and well-being. Rehabilitation of geriatric patients is imperative for the patients’ well-being and for society, so that we can thrive socially and economically. Essential to geriatric rehabilitation is communication, specifically improving any sensory impairment, including those related to vision and hearing. OBM Geriatrics is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc.

Editorial Board

Special Issues

Newsletter

TOP